BeginnerEducationOverview

What Are Peptides? Complete Beginner's Guide 2026

Peptides explained from the ground up: what they are, how they work, the main types used in research, safety status, and how to start evaluating them.

PeptidesRated·April 17, 2026·10 min read
What Are Peptides? Complete Beginner's Guide 2026 — PeptidesRated guide hero image

You have been hearing the word "peptides" everywhere. Recovery forums, biohacking podcasts, fitness subreddits, news articles about FDA decisions. Some of it sounds like miracle-drug marketing. Some of it reads like real science.

Here's the honest version: what peptides actually are, how they work, what the research shows (and where it's thin), and how to start making sense of it if you're new.

What Are Peptides, Exactly?

A peptide is a chain of amino acids. Amino acids are the building blocks of proteins. When you link two or more of them together with a chemical bond, you get a peptide. When you link 50 or more together into a larger structure, you get a protein.

That's the technical definition. But it misses why peptides matter for health research.

The body uses peptides as signaling molecules. Your digestive system produces GLP-1 (glucagon-like peptide-1) naturally to regulate blood sugar and satiety after meals. Growth hormone-releasing hormone (GHRH) is a peptide your hypothalamus uses to signal the pituitary gland. Thymosin Beta-4 is a peptide your body produces to support tissue repair. BPC-157 is derived from a protein found naturally in gastric juice.

What makes synthetic peptides interesting is the ability to produce them in larger amounts, stabilize them, or modify their structure to extend their half-life or change how they work. The semaglutide in Ozempic, for instance, is a GLP-1 analogue: a modified version of the natural GLP-1 peptide engineered to last a week rather than a few minutes.

How Peptides Work

Most peptides work by binding to specific receptors on cell surfaces. Think of receptors as locks and peptides as keys. The right peptide binds to its receptor, triggers a signal inside the cell, and produces a downstream effect.

Different peptides target different receptor systems:

BPC-157 works through growth factor signaling: upregulates VEGF (vascular endothelial growth factor), FGFR2, and modulates nitric oxide to drive tissue healing.
TB-500 (Thymosin Beta-4 fragment) binds G-actin and promotes cellular migration to injury sites.
Semaglutide binds GLP-1 receptors in the gut, brain, and pancreas to reduce appetite and improve insulin sensitivity.
CJC-1295 binds the GHRH receptor on the pituitary to stimulate growth hormone release.
GHK-Cu (copper peptide) activates wound healing genes and promotes collagen synthesis.

The specificity is what makes peptides interesting from a research perspective. Unlike many small-molecule drugs, peptides typically target one receptor system with relatively high precision. That specificity is also why side effect profiles can be more manageable than broad-acting compounds.

Types of Research Peptides

Here is a practical breakdown of the main categories and what each is studied for:

CategoryKey peptidesPrimary research area
Healing & RecoveryBPC-157, TB-500Tissue repair, tendon healing, gut healing
GLP-1 / Weight LossSemaglutide, TirzepatideAppetite regulation, metabolic health
Growth HormoneCJC-1295, IpamorelinGH pulse stimulation, muscle, recovery
Anti-Aging / SkinGHK-Cu, EpithalonCollagen, skin quality, telomere research
CognitiveSemax, SelankBDNF upregulation, anxiety, focus
Sexual HealthPT-141 (Bremelanotide)Libido, arousal (FDA-approved for women)

This list is not exhaustive. The peptide research space is large and growing. New compounds are studied regularly, and the evidence quality varies significantly across categories.

What the Research Actually Shows

Here's the honest picture of evidence quality across the major categories:

Strong clinical evidence (human trials):

Semaglutide and tirzepatide: large-scale Phase 3 trials with thousands of participants. The STEP 1 and SURMOUNT-1 results are solid.
PT-141 (Bremelanotide): FDA approved for hypoactive sexual desire disorder in premenopausal women.

Promising animal research, limited human data:

BPC-157: extensive animal model research from Sikiric's lab spanning 25+ years. Consistent results in rodent models for gut healing, tendon repair, and nerve regeneration. Human clinical trial data is limited. The mechanisms are well-understood; the translation to humans is not yet fully established.
TB-500: significant in vitro and animal research. Some human-adjacent cardiac studies. No large-scale RCTs.
CJC-1295 + Ipamorelin: GH-stimulating effects well-documented in small human studies. Long-term outcomes are not established.

Mostly preclinical:

Epithalon: interesting telomere research, mostly Russian studies from the 1980s-2000s. Small human studies, limited replication.
Semax and Selank: significant Russian clinical use (both approved as drugs in Russia). Western peer-reviewed data is thin.

What most people miss: the "it only has animal studies" criticism is not a blanket disqualifier. BPC-157's animal research is among the most consistent in the space. But it does mean you cannot make the same confidence claims as you can about semaglutide. The hierarchy of evidence matters.

This is where it gets complicated, and where precision matters.

FDA-approved peptides: Semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and PT-141 (Vyleesi) are FDA-approved drugs available by prescription.

Compounded peptides: During drug shortages, 503A/503B compounding pharmacies can legally compound FDA-approved molecules like semaglutide. The landscape here changed in 2024-2025 as shortage designations were updated.

Research peptides: Most other peptides (BPC-157, TB-500, GHK-Cu, CJC-1295, Semax, etc.) are not FDA-approved for human use. They are sold by research chemical suppliers under "for research use only" labeling. Their legal status varies by country.

Safety profile: most research peptides have not undergone the systematic human safety studies that FDA-approved drugs require. What we know comes from animal toxicology, limited human case reports, and large community-reported experience. The absence of serious adverse event reports for compounds like BPC-157 and GHK-Cu in the research community is reassuring, but it's not the same as a clinical trial safety profile.

Two non-negotiables for any peptide:

Talk to your doctor before starting. This is especially true for GLP-1 agonists (contraindications exist), GH-releasing peptides (affects hormone systems), and anything you plan to inject.
Verify quality independently. Purity and sterility matter more for injectables than almost any other research compound. Third-party Certificate of Analysis (COA) data from a named lab is the minimum standard.

How to Evaluate Peptide Quality

The research peptide market has no FDA oversight for most compounds. This means quality varies enormously between suppliers. A "99% pure" claim on a supplier website means nothing without documentation.

What to look for:

Batch-specific COA from a named third-party lab. Janoshik Analytical is the most commonly used lab. Others include Finnrick and Freedom Diagnostics. The lab name should be specific, not "a certified U.S. lab."
HPLC purity data. High-performance liquid chromatography confirms the compound's identity and purity percentage.
Accessible before purchase. You should be able to verify the COA before paying, not after.
Endotoxin testing for injectables. Bacterial endotoxins cause inflammation and fever. This test matters specifically for anything you plan to inject.

Use the COA lookup tool at peptidesrated.com/coa-lookup to cross-check batch numbers against verified third-party lab results before ordering from any supplier.

Where to Start

If you are new to peptides and want to research them sensibly, here is a reasonable starting sequence:

Start with the peptides that have the strongest evidence for your specific goal. For weight loss, semaglutide and tirzepatide have the best clinical data. For tissue healing, BPC-157 and TB-500 are the most-studied compounds.
Read the research, not just forum posts. PubMed is free. If a compound has 20+ animal studies with consistent results and a coherent mechanism, that matters.
Talk to a physician before starting anything injectable, and before any compound that interacts with hormone systems.
Verify suppliers before ordering. Check COA data, confirm third-party testing, and read community reviews.

For individual compound guides, see peptidesrated.com/peptide/bpc-157 and peptidesrated.com/peptide/semaglutide. For supplier comparisons with verified testing data, see peptidesrated.com/compare.

Sources

1. Lau JL, Dunn MK. Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorganic & Medicinal Chemistry. 2018;26(10):2700-2707. PMID: 28784303.

2. Vlieghe P et al. Synthetic therapeutic peptides: science and market. Drug Discovery Today. 2010;15(1-2):40-56. PMID: 19879957.

3. Sikiric P et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current Pharmaceutical Design. 2011;17(16):1612-1632. PMID: 21548867.

4. Goldstein AL et al. Thymosin: biology and clinical applications. Expert Opinion on Biological Therapy. 2006;6(7):647-662. PMID: 16787153.

5. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM. 2021;384(11):989-1002. PMID: 33567185.

6. FDA Prescribing Information: Vyleesi (bremelanotide injection). NDA 210557.

7. Guevara-Aguirre J et al. CJC-1295 and Ipamorelin research. Growth Hormone & IGF Research, 2010.

What is the difference between a peptide and a protein?

Convention puts the dividing line at around 50 amino acids: peptides are shorter chains, proteins are longer. In practice, some peptides blur this line. What matters functionally is that peptides are typically smaller, more targeted signaling molecules, while proteins have more complex folded structures. Semaglutide is 31 amino acids. Insulin is 51 amino acids and is typically classified as a small protein.

Do peptides actually work?

It depends which peptide and for what purpose. GLP-1 agonists like semaglutide have the strongest evidence: Phase 3 trial data showing 15-20% average weight loss. BPC-157 has 25+ years of consistent animal model research but limited human trial data. Other compounds range from well-studied to barely researched. The honest answer is "some do, with strong evidence; others are promising but need more human data."

Are research peptides legal?

In the US, most research peptides are legal to purchase for laboratory research purposes. They cannot be legally marketed for human consumption. FDA-approved peptides (semaglutide, tirzepatide, PT-141) are legal with a prescription or from a licensed compounding pharmacy. Legal status varies significantly by country. Verify your local regulations before ordering.

Do you need to inject peptides?

Most research peptides require subcutaneous injection for reliable bioavailability. Oral administration generally does not work because the digestive system breaks peptides down before they can be absorbed. The exception is BPC-157 in its arginine salt form, which shows systemic effects via oral dosing in animal studies. GLP-1 medications like semaglutide are also available in oral form (Rybelsus), though injectable versions have better bioavailability data.

How do I know if a peptide supplier is legitimate?

The minimum standard: batch-specific COA data from a named third-party testing lab (not just "certified lab") available before purchase. HPLC purity data showing 98%+ for most research peptides. Community verification (r/Peptides and similar forums maintain supplier reputation lists). Avoid any supplier who cannot produce batch-specific test results on request. For a starting point on vetted suppliers, see peptidesrated.com/compare.

Continue exploring

Ready to find a supplier?

Compare providers on testing transparency, pricing, and COA access.

Stay up to date

New COA batches, supplier reviews, and peptide guides — delivered weekly.

Disclaimer

This article is for informational and educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any peptide therapy.